HEALIOS K.K.
4593・Growth Market・Pharmaceuticals
Governance
The Company has adopted the Company with Nominating Committee, etc. structure. The Board of Directors consists of 5 members (3 outside directors, 60% outside ratio), and three committees—Nominating, Audit, and Compensation—have been established. All directors attended all Board of Directors meetings (held 10 times per year), aiming to enhance transparency and objectivity through the separation of oversight and execution.
Risk Management
Based on the Risk Management Regulations, the Human Resources and General Affairs Division oversees company-wide risk management and periodically reports issues and countermeasures to the Representative Director and President. In addition to regular status analysis and risk assessment by the Internal Audit Committee, the Company has established specialized committees such as the Research Ethics Review Committee and the Biosafety Committee, building a system to ensure compliance with laws and international standards.
Shareholder Returns
No dividends have been paid since founding. The annual dividend is ¥0 for both FY2025 (ending December 2025) and FY2026 (ending December 2026). The company prioritizes upfront investment in pharmaceutical development and does not plan to pay dividends for the time being. No mention of share buybacks is found in this financial results report.
Dividend Policy
The annual dividend for FY2025 (ending December 2025) is ¥0 (¥0 at second quarter-end, ¥0 at fiscal year-end). The forecast for FY2026 (ending December 2026) is also ¥0 for the full year (¥0 at second quarter-end, ¥0 at fiscal year-end). For the time being, the company prioritizes securing funds to support the continued implementation of R&D activities and does not plan to pay dividends.
ESG
Under its mission to "increase living," the company positions social contribution through regenerative medicine for intractable diseases as the core of its sustainability management. In terms of human capital, it sets forth a strategy of securing highly skilled personnel from around the world and promoting diversity, but explains that disclosing numerical targets is difficult given its workforce of fewer than 100 employees. On climate change response, it merely indicates directions such as introducing renewable energy, energy conservation, and waste reduction, with specific indicators and targets yet to be established.
Last updated: March 24, 2026